<a id="pl.1.3"></a><var>1.3</var>for the treatment of epilepsy or seizures;amending Minnesota Statutes 2008, <br/>
<a id="pl.1.4"></a><var>1.4</var>section 151.06, subdivision 1.<br/>
<a id="pl.1.5"></a><var>1.5</var>BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:<br/>
<br/>
<a id="bill.0.1.0"></a><a id="pl.1.6"></a><var>1.6</var>    Section 1. Minnesota Statutes 2008, section 151.06, subdivision 1, is amended to read:<br/>
<a id="pl.1.7"></a><var>1.7</var>    Subdivision 1. <b>Generally; rules.</b> (a) Powers and duties. The Board of Pharmacy <br/>
<a id="pl.1.8"></a><var>1.8</var>shall have the power and it shall be its duty: <br/>
<a id="pl.1.9"></a><var>1.9</var>    (1) to regulate the practice of pharmacy;<br/>
<a id="pl.1.10"></a><var>1.10</var>    (2) to regulate the manufacture, wholesale, and retail sale of drugs within this state;<br/>
<a id="pl.1.11"></a><var>1.11</var>    (3) to regulate the identity, labeling, purity, and quality of all drugs and medicines <br/>
<a id="pl.1.12"></a><var>1.12</var>dispensed in this state, using the United States Pharmacopeia and the National Formulary, <br/>
<a id="pl.1.13"></a><var>1.13</var>or any revisions thereof, or standards adopted under the federal act as the standard;<br/>
<a id="pl.1.14"></a><var>1.14</var>    (4) to enter and inspect by its authorized representative any and all places where <br/>
<a id="pl.1.15"></a><var>1.15</var>drugs, medicines, medical gases, or veterinary drugs or devices are sold, vended, given <br/>
<a id="pl.1.16"></a><var>1.16</var>away, compounded, dispensed, manufactured, wholesaled, or held; it may secure samples <br/>
<a id="pl.1.17"></a><var>1.17</var>or specimens of any drugs, medicines, medical gases, or veterinary drugs or devices <br/>
<a id="pl.1.18"></a><var>1.18</var>after paying or offering to pay for such sample; it shall be entitled to inspect and make <br/>
<a id="pl.1.19"></a><var>1.19</var>copies of any and all records of shipment, purchase, manufacture, quality control, and <br/>
<a id="pl.1.20"></a><var>1.20</var>sale of these items provided, however, that such inspection shall not extend to financial <br/>
<a id="pl.1.21"></a><var>1.21</var>data, sales data, or pricing data;<br/>
<a id="pl.1.22"></a><var>1.22</var>    (5) to examine and license as pharmacists all applicants whom it shall deem qualified <br/>
<a id="pl.1.23"></a><var>1.23</var>to be such;<br/>
<a id="pl.1.24"></a><var>1.24</var>    (6) to license wholesale drug distributors;<br/>
<a id="pl.2.1"></a><var>2.1</var>    (7) to deny, suspend, revoke, or refuse to renew any registration or license required <br/>
<a id="pl.2.2"></a><var>2.2</var>under this chapter, to any applicant or registrant or licensee upon any of the following <br/>
<a id="pl.2.3"></a><var>2.3</var>grounds:<br/>
<a id="pl.2.4"></a><var>2.4</var>    (i) fraud or deception in connection with the securing of such license or registration;<br/>
<a id="pl.2.5"></a><var>2.5</var>    (ii) in the case of a pharmacist, conviction in any court of a felony;<br/>
<a id="pl.2.6"></a><var>2.6</var>    (iii) in the case of a pharmacist, conviction in any court of an offense involving <br/>
<a id="pl.2.7"></a><var>2.7</var>moral turpitude;<br/>
<a id="pl.2.8"></a><var>2.8</var>    (iv) habitual indulgence in the use of narcotics, stimulants, or depressant drugs; <br/>
<a id="pl.2.9"></a><var>2.9</var>or habitual indulgence in intoxicating liquors in a manner which could cause conduct <br/>
<a id="pl.2.10"></a><var>2.10</var>endangering public health;<br/>
<a id="pl.2.11"></a><var>2.11</var>    (v) unprofessional conduct or conduct endangering public health;<br/>
<a id="pl.2.12"></a><var>2.12</var>    (vi) gross immorality;<br/>
<a id="pl.2.13"></a><var>2.13</var>    (vii) employing, assisting, or enabling in any manner an unlicensed person to <br/>
<a id="pl.2.14"></a><var>2.14</var>practice pharmacy;<br/>
<a id="pl.2.15"></a><var>2.15</var>    (viii) conviction of theft of drugs, or the unauthorized use, possession, or sale thereof;<br/>
<a id="pl.2.16"></a><var>2.16</var>    (ix) violation of any of the provisions of this chapter or any of the rules of the State <br/>
<a id="pl.2.17"></a><var>2.17</var>Board of Pharmacy;<br/>
<a id="pl.2.18"></a><var>2.18</var>    (x) in the case of a pharmacy license, operation of such pharmacy without a <br/>
<a id="pl.2.19"></a><var>2.19</var>pharmacist present and on duty;<br/>
<a id="pl.2.20"></a><var>2.20</var>    (xi) in the case of a pharmacist, physical or mental disability which could cause <br/>
<a id="pl.2.21"></a><var>2.21</var>incompetency in the practice of pharmacy;<br/>
<a id="pl.2.22"></a><var>2.22</var>    (xii) in the case of a pharmacist, the suspension or revocation of a license to practice <br/>
<a id="pl.2.23"></a><var>2.23</var>pharmacy in another state; or<br/>
<a id="pl.2.24"></a><var>2.24</var>    (xiii) in the case of a pharmacist, aiding suicide or aiding attempted suicide in <br/>
<a id="pl.2.25"></a><var>2.25</var>violation of section 
         <statute_ref>609.215</statute_ref> as established by any of the following: <br/>
<a id="pl.2.26"></a><var>2.26</var>    (A) a copy of the record of criminal conviction or plea of guilty for a felony in <br/>
<a id="pl.2.27"></a><var>2.27</var>violation of section 
         <statute_ref>609.215, subdivision 1</statute_ref> or 2; <br/>
<a id="pl.2.28"></a><var>2.28</var>    (B) a copy of the record of a judgment of contempt of court for violating an <br/>
<a id="pl.2.29"></a><var>2.29</var>injunction issued under section 
         <statute_ref>609.215, subdivision 4</statute_ref>; <br/>
<a id="pl.2.30"></a><var>2.30</var>    (C) a copy of the record of a judgment assessing damages under section 
         <statute_ref>609.215, <br/>
<a id="pl.2.31"></a><var>2.31</var>subdivision 5
         </statute_ref>; or <br/>
<a id="pl.2.32"></a><var>2.32</var>    (D) a finding by the board that the person violated section 
         <statute_ref>609.215, subdivision <br/>
<a id="pl.2.33"></a><var>2.33</var>1
         </statute_ref> or 2. The board shall investigate any complaint of a violation of section 
         <statute_ref>609.215, <br/>
<a id="pl.2.34"></a><var>2.34</var>subdivision 1
         </statute_ref> or 2; <br/>
<a id="pl.2.35"></a><var>2.35</var>    (8) to employ necessary assistants and adopt rules for the conduct of its business;<br/>
<a id="pl.3.1"></a><var>3.1</var>    (9) to register as pharmacy technicians all applicants who the board determines are <br/>
<a id="pl.3.2"></a><var>3.2</var>qualified to carry out the duties of a pharmacy technician; and<br/>
<a id="pl.3.3"></a><var>3.3</var>    (10) to perform such other duties and exercise such other powers as the provisions of <br/>
<a id="pl.3.4"></a><var>3.4</var>the act may require.<br/>
<a id="pl.3.5"></a><var>3.5</var>    (b) Temporary suspension. In addition to any other remedy provided by law, the <br/>
<a id="pl.3.6"></a><var>3.6</var>board may, without a hearing, temporarily suspend a license for not more than 60 days if <br/>
<a id="pl.3.7"></a><var>3.7</var>the board finds that a pharmacist has violated a statute or rule that the board is empowered <br/>
<a id="pl.3.8"></a><var>3.8</var>to enforce and continued practice by the pharmacist would create an imminent risk of <br/>
<a id="pl.3.9"></a><var>3.9</var>harm to others. The suspension shall take effect upon written notice to the pharmacist, <br/>
<a id="pl.3.10"></a><var>3.10</var>specifying the statute or rule violated. At the time it issues the suspension notice, the <br/>
<a id="pl.3.11"></a><var>3.11</var>board shall schedule a disciplinary hearing to be held under the Administrative Procedure <br/>
<a id="pl.3.12"></a><var>3.12</var>Act. The pharmacist shall be provided with at least 20 days' notice of any hearing held <br/>
<a id="pl.3.13"></a><var>3.13</var>under this subdivision. <br/>
<a id="pl.3.14"></a><var>3.14</var>    (c) Rules. For the purposes aforesaid, it shall be the duty of the board to make <br/>
<a id="pl.3.15"></a><var>3.15</var>and publish uniform rules not inconsistent herewith for carrying out and enforcing <br/>
<a id="pl.3.16"></a><var>3.16</var>the provisions of this chapter. The board shall adopt rules regarding prospective drug <br/>
<a id="pl.3.17"></a><var>3.17</var>utilization review and patient counseling by pharmacists. A pharmacist in the exercise of <br/>
<a id="pl.3.18"></a><var>3.18</var>the pharmacist's professional judgment, upon the presentation of a new prescription by a <br/>
<a id="pl.3.19"></a><var>3.19</var>patient or the patient's caregiver or agent, shall perform the prospective drug utilization <br/>
<a id="pl.3.20"></a><var>3.20</var>review required by rules issued under this subdivision. <br/>
<a id="pl.3.21"></a><var>3.21</var>(d) Substitution; rules. If the United States Food and Drug Administration <br/>
<a id="pl.3.22"></a><var>3.22</var>determines that the substitution of drugs used for the treatment of epilepsy or seizures <br/>
<a id="pl.3.23"></a><var>3.23</var>poses a health risk to patients, the board shall adopt rules in accordance with accompanying <br/>
<a id="pl.3.24"></a><var>3.24</var>FDA interchangeability standards regarding the use of substitution for these drugs. If the <br/>
<a id="pl.3.25"></a><var>3.25</var>board adopts a rule regarding the substitution of drugs used for the treatment of epilepsy <br/>
<a id="pl.3.26"></a><var>3.26</var>or seizures that conflicts with the substitution requirements of section 151.21, subdivision <br/>
<a id="pl.3.27"></a><var>3.27</var>3, the rule shall supersede the conflicting statute. If the rule proposed by the board would <br/>
<a id="pl.3.28"></a><var>3.28</var>increase state costs for state public health care programs, the board shall report to the <br/>
<a id="pl.3.29"></a><var>3.29</var>legislature the proposed rule and the increased cost associated with the proposed rule, <br/>
<a id="pl.3.30"></a><var>3.30</var>before the board may adopt the rule.<br/>